SAN DIEGO, Feb. 5 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals,
Inc. (Amex: ANX), a biopharmaceutical research and development company
focused on commercializing proprietary product candidates for the treatment
of cancer and infectious diseases, announced today that Evan M. Levine,
ADVENTRX's chief executive officer and president, is scheduled to present
at the 10th Annual BIO CEO & Investor Conference on February 12, 2008 at
10:15 a.m. Eastern Time. The conference takes place in New York at the
Waldorf Astoria hotel, February 11-13, 2008.
The presentation will be webcast live via the "Investors" section of
the Company's web site at http://www.adventrx.com under "Events." The
webcast will be available for replay for 14 days and can be accessed
through the same link.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a biopharmaceutical research and
development company focused on commercializing proprietary product
candidates for the treatment of cancer and infectious diseases. The Company
seeks to improve the performance and safety of existing treatments by
addressing significant problems such as drug metabolism, bioavailability,
excessive toxicity and treatment resistance. More information can be found
on the Company's web site at http://www.adventrx.com.
SOURCE ADVENTRX Pharmaceuticals, Inc.
 back to top
Related links:
http://www.adventrx.com
CONTACT:
Investors, Ioana C. Hone of ADVENTRX
Pharmaceuticals, Inc., +1-858-552-0866
|
